The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. (Q39281793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rocco Cappellesso

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Ambrogio Fassina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Filippo Marino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Maayan Siri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Renato Zambello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Laura Ventura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Francesca Simonato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

1 reference

10 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1574-1582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22964854%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.129

12 February 2020

exact match

0 references

cites work

Prognostic biomarkers in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

miRNAs in precancerous lesions of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MicroRNAs in immune regulation--opportunities for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Epithelial-mesenchymal transition in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MicroRNA expression profiling in human Barrett's carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Incidence, risk factors and outcome of histological transformation in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Follicular lymphoma: 2011 update on diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

Histologic conversion in the non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021

Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.129

7 January 2021